Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: GPCR position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on GPCR, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 51,262 GPCR shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 51,262 shares
    Change vs previous 13F +5,901 shares

    0.05% of the 13F portfolio, value $2,751,232.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 45,361 shares
    Change vs previous 13F -930 shares

    0.04% of the 13F portfolio, value $2,186,400.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 46,291 shares
    Change vs previous 13F +42,213 shares

    0.07% of the 13F portfolio, value $3,246,444.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 4,078 shares
    Change vs previous 13F +1,146 shares

    <0.01% of the 13F portfolio, value $114,193.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 2,932 shares
    Change vs previous 13F -1,315 shares

    <0.01% of the 13F portfolio, value $60,814.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 4,247 shares
    Change vs previous 13F +3,213 shares

    <0.01% of the 13F portfolio, value $73,521.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 1,034 shares
    Change vs previous 13F +553 shares

    <0.01% of the 13F portfolio, value $28,044.

    13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 481 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $21,113.

    13F-HR 0001652442-24-000006 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).